GKWIM
CRDF icon

Gerber Kawasaki Wealth & Investment Management’s Cardiff Oncology CRDF Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed – – 449
2021
Q3 		$0 Buy
+1
New +$6 ﹤0.01% 1185

Other funds holding CRDF

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's CRDF Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Cardiff Oncology (CRDF) in Q4 2021, closing a stake of 1 share.

Gerber Kawasaki Wealth & Investment Management first reported a position in CRDF in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 87 funds tracked by Wall St. Rank hold CRDF as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Cardiff Oncology position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 1 Cardiff Oncology share in Q4 2021.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Cardiff Oncology in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Cardiff Oncology position peaked at $0 in Q3 2021.
  • 87 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.